Catalyst Pharmaceuticals, Inc. (CPRX)

NASDAQ: CPRX · Real-Time Price · USD

23.23

-0.16 (-0.68%)

At close: Mar 13, 2026, 4:00 PM EDT

23.71

+0.48 (2.07%)

After-hours: Mar 13, 2026, 7:45 PM EDT

Catalyst Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	709.17	517.55	137.64	298.4	171.45
Short-Term Investments	-	-	-	-	19.82
Cash & Short-Term Investments	709.17	517.55	137.64	298.4	191.27
Cash Growth	37.02%	276.03%	-53.87%	56.01%	36.35%
Accounts Receivable	126.48	65.48	53.51	10.44	6.62
Inventory	37.17	19.54	15.64	6.81	7.87
Other Current Assets	21.22	21.04	12.54	5.17	4.35
Total Current Assets	894.03	623.61	219.33	320.81	210.11
Net Property, Plant & Equipment	2.97	3.58	3.7	3.62	3.98
Other Intangible Assets	131.67	156.67	194.05	32.47	-
Long-Term Investments	22.54	21.56	16.49	-	-
Other Long-Term Assets	52.77	45.98	36.54	18.74	23.71
Total Assets	1,104	851.41	470.11	375.63	237.79
Accounts Payable	11.2	16.59	14.8	3.98	2.77
Accrued Expenses	135.95	104.09	61.27	53.61	24.3
Total Current Liabilities	147.15	120.68	76.06	57.59	27.06
Long-Term Leases	2.35	2.79	3.19	3.56	3.89
Other Long-Term Liabilities	0.21	0.32	2.98	14.06	-
Total Long-Term Liabilities	2.56	3.1	6.17	17.62	3.89
Total Liabilities	149.71	123.78	82.23	75.21	30.96
Common Stock	0.12	0.12	0.11	0.11	0.1
Additional Paid-in Capital	479.96	442.29	266.49	250.43	233.19
Accumulated Other Comprehensive Income	-	0.06	0.01	0.02	-0.15
Retained Earnings	474.19	285.16	121.27	49.86	-26.31
Shareholders' Equity	954.27	727.63	387.88	300.42	206.83
Total Liabilities & Equity	1,104	851.41	470.11	375.63	237.79
Total Debt	2.35	2.79	3.19	3.56	3.89
Net Cash (Debt)	706.82	514.77	134.45	294.84	187.37
Net Cash Growth	37.31%	282.87%	-54.40%	57.35%	33.57%
Net Cash Per Share	5.55	4.12	1.18	2.65	1.74
Book Value	954.27	727.63	387.88	300.42	206.83
Book Value Per Share	7.50	5.82	3.41	2.70	1.92
Tangible Book Value	822.59	570.96	193.83	267.95	206.83
Tangible Book Value Per Share	6.46	4.57	1.70	2.41	1.92

Updated Feb 25, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q